Southern California Thyroid Cancer Consortium

Who we are: Established in 2007, the Southern California Thyroid Cancer Consortium is a network of thyroid cancer specialists serving the large, ethnically and socially diverse thyroid cancer population in Southern California (greater Los Angeles, Irvine, Newport Beach, San Diego). The consortium is comprised of physician-investigators at major academic, public and private institutions with a focus on thyroid cancer.

Our Mission: The intent of this consortium is to offer our thyroid cancer patients investigative, cutting edge diagnostic and therapeutic clinical trials which are not currently available to individual practicing clinicians in Southern California.

The Southern California Thyroid Cancer Consortium is committed to:

  • Forming research partnerships with the National Cancer Institute, other National and International thyroid cancer centers as well as private industry.
  • An innovative and multidisciplinary approach to thyroid cancer which includes the specialties of endocrinology, oncology, surgery, pathology, nuclear medicine, and radiology.
  • A high level of collegiality.

If you would like to join our mailing list please send an e-mail to

Consortium Chair:
Jerome M. Hershman, MD
Distinguished Professor of Medicine
David Geffen School of Medicine at UCLA
VA Greater Los Angeles Healthcare System
Endocrinology 111D
11301 Wilshire Blvd.
Los Angeles, CA 90073
Phone: 310-268-3850
Fax: 310-268-4879
Consortium Secretary:
Andrew G. Gianoukakis, MD
Professor of Medicine
David Geffen School of Medicine at UCLA
Director, Thyroid Oncology Clinic
Division of Endocrinology and Metabolism
The Lundquist Institute at
Harbor-UCLA Medical Center
1124 W. Carson St. RB-1
Torrance, CA 90502
Phone: 310-222-8172
Fax: 310-533-0627